Literature DB >> 423530

In vivo responses to inhaled proteins. II. Induction of interstitial pneumonitis and enhancement of immune complex-mediated alveolitis by inhaled concanavalin A.

W F Willoughby, J B Willoughby, B B Cantrell, R Wheelis.   

Abstract

An animal model of environmental lung disease is described in which phytomitogen, antigen, or both, are administered in aerosol form to previously immunized or immunologically naive rabbits. Inhalation of concanavalin A alone induced an interstitial pneumonitis in nonimmunized rabbits. Inhalation of concanavalin A alone induced an interstitial pneumonitis in nonimmunized rabbits. Inhalation of bovine serum albumin (BSA) alone typically produced only focal eosinophilic granulomas in BSA-immunized animals, and no injury whatever in nonimmune animals. However, simultaneous administration of BSA-concanavalin A aerosol mixtures to BSA-immunized rabbits induced a severe interstitial pneumonitis and granulomatous vasculitis, together with areas of frank parenchymal necrosis. When repeated on a chronic basis over a 4- or 8-week interval, challenge with BSA-concanavalin A aerosols resulted in both acute necrotic lesions as well as areas of frank interstitial fibrosis. Necrotic foci in acutely injured lungs were associated with interstitial deposits of BSA, rabbit anti-BSA antibody, and complement. Electron microscopy revealed numerous neutrophils within the pulmonary interstitial spaces of these animals, often in association with collagen and elastin fibers. The pattern of injury in immune rabbits induced by antigen-concanavalin A aerosols, in its nonnecrotizing form, is consistent with that of an extrinsic allergic alveolitis. However, the severe, necrotizing form of acute injury closely resembles changes seen in Wegener's granulomatosis. Possible mechanisms of injury produced by antigen and phytomitogen inhalation are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 423530

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

Review 1.  Polyclonal activators in pulmonary immune disease.

Authors:  W F Willoughby; J B Willoughby; G F Gerberick
Journal:  Clin Rev Allergy       Date:  1985-05

2.  Lectins.

Authors:  D L Freed
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-23

3.  Serum antibody response and germinal centre reaction in the upper respiratory tract after antigen challenge in mice.

Authors:  U Schumacher; A Beigel; H K Müller-Hermelink; H Lehmann
Journal:  Arch Otorhinolaryngol       Date:  1984

4.  Chronic hypersensitivity pneumonitis produced in the rabbit by the adjuvant effect of inhaled muramyl dipeptide (MDP).

Authors:  H B Richerson; M T Suelzer; P A Swanson; J E Butler; W C Kopp; E F Rose
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

5.  Immune complex-mediated lung injury produced by horseradish peroxidase (HRP) and anti-HRP antibodies in rats.

Authors:  B Bellon; J F Bernaudin; C Mandet; B Chamak; J Kuhn; P Druet
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

Review 6.  Immunologic mechanisms of parenchymal lung injury.

Authors:  W F Willoughby; J B Willoughby
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

Review 7.  Particles causing lung disease.

Authors:  K H Kilburn
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

8.  Serum factor requirement for reactive oxygen intermediate release by rabbit alveolar macrophages.

Authors:  G F Gerberick; J B Willoughby; W F Willoughby
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.